Ivermectin and the Integrity of Healthcare Evidence During COVID-19.

ABSTRACT: The COVID-19 pandemic has been characterized by a lack of clear evidence to guide healthcare professionals, the public and policymakers. The resulting uncertainty, coupled with changing guidelines as additional evidence became available, added to the stress and anxiety reported by decision-makers. Research results are key to providing evidence to guide healthcare decisions. Important questions have arisen about whether various interventions are safe and effective. The evidence found guides those making treatment decisions, and influences those selecting interventions for further evaluation in research studies. As the COVID-19 pandemic intensified, the effectiveness and safety of many pharmaceuticals was queried. Ivermectin will be used to explore the ethics of how healthcare evidence must

SUBMITTER: O'Mathuna DP 

PROVIDER: S-EPMC8921859 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature